Skip Navigation
Johns Hopkins Bloomberg School of Public Health
spacer

Global Research

Project Map

Operational Research for Cryptococcal antigen screening to improve ART survival

Kampala, Uganda

Dates

Start Date:
06/01/2012
End Date:
05/31/2016

Project Type

Summary

This will be a phased-in, randomized trial design to evaluate the implementation of CRAG screening and pre-emptive antifungal therapy of HIV-infected persons entering ART outpatient treatment. Those who are ART eligible with a CD4=100 cells/µL will have a serum CRAG performed by lateral flow assay. Those who are CRAG positive and asymptomatic will be treated with high dose fluconazole. After 6 months survival and cryptococcal meningitis free survival will be compared between those who are CRAG+ and CRAG negative.

Locations

Researchers

Centers

spacerspacerspacer

Council on Education for Public Health

 Johns Hopkins University

©2014, Johns Hopkins University. All rights reserved.
Web policies, 615 N. Wolfe Street, Baltimore, MD 21205

interest